Evaluation of an App Based on Artificial Intelligence for Pain Assessment in Pediatric Department (DEF II)

January 11, 2024 updated by: Centre Hospitalier Universitaire de Nice

Development and Validation of a System Based on Digital Face Recognitation for Pain Assessment in Children's Emergency

Accurate assessment of pain in Pediatric Department is challenging. However, recent publications highlight that children do not receive optimal pain management, particularly in Emergency Departments.

An Artificial Intelligence-based tool could help physicians to optimize analgesia use.

Study Overview

Status

Completed

Conditions

Detailed Description

Acute pain is the reason that the majority of patients present to the Emergency Department. Multiple studies conducted over many years have demonstrated that pain is poorly managed in the Emergency Department. This phenomenon has been referred to in the Medical Literature as "Oligoanalgesia.". Morever, untreated pain can have short and long term effects in Pediatric population, including sensitisation to pain episodes in later life and can affects the Neurodevelopment of the child.

The generally accepted standard for pain assessment is self-reported; however, in preverbal children who cannot communicate their pain, age-appropriate behavioural or observational pain assessment tools are recommended. Because children are not always able to voice their feelings, they completely depend on their caregiving team for the interpretation and management of their pain and discomfort. Thus, accurately validated scales to assess pain levels are crucial. In France, the EVENDOL is the most used widely scale. The EVENDOL scale (from the French Evaluation Enfant Douleur) is used to evaluate pain in children in any situation covering a wider age group than other pain scales (birth up to seven years). Despite a large number of scales with a variety of Psychometric properties having been published in the last decades, to date, there is no criterion standard when considering the assessment of pain. As a result, children continue to be suffered pain without adequate pain management. International guidelines incorporate the need for prompt recognition of pain.

Artificial Intelligence (AI) in Medicine is booming and has already proven its worth in terms of prevention, monitoring and diagnosis. AI in this field can be used to support clinician decision making, allow curiosity-driven care, remove the need to complete mundane tasks, improve communication, and facilitate collaboration. Evaluation of the face is central to all observational pain assessment tools, as the face is highly accessible and facial expressions are considered the most encodable feature of pain Therefore.the investigators aim to develop, validate and asses a system based on Digital Face Recognitation for pain assessment in the Children's Department.

Study Type

Observational

Enrollment (Actual)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nice, France, 06000
        • Hopital pédiatrique Fondation Lenval
        • Principal Investigator:
          • Antoine TRAN
    • Chu de Nice
      • Nice, Chu de Nice, France, 06003
        • CHU de Nice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

2000 patients under 18 year old admitted in Emergency Department

Description

Inclusion Criteria:

  • Child under 18
  • Informed and written consent of a parent or guardian (only 1 accompanying person allowed).

Exclusion Criteria:

  • Language barrier.
  • Refusal to participate by parents/children
  • Sign of collapsus, or in serious clinical condition (stage I or II) requiring absolute emergency care,
  • Delayed mental or staturo-ponderal development
  • Facial injury or wound, presence of a bandage on the face, pre-existing facial deformity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
assessment of pain in Pediatric Department
2000 children patients admitted in emmergency department
the facial expression of each patient will be collected from a short video of 10 seconds, follow by with the evaluation of the pain intensity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
assessment of The intensity of acute pain with the EVENDOL Scale
Time Frame: day 0
The intensity of acute pain will be assessed by the current reference French methods for evaluating pain in children with the EVENDOL Scale (reference between 0 and 7 years).
day 0
assessment of The intensity of acute pain with the VAS Scale
Time Frame: day 0
The intensity of acute pain will be assessed by the current reference French methods for evaluating pain in children with the VAS Scale (Age > 7 years)
day 0
the facial expression captured by short video
Time Frame: day 0
a short 10-second video is collected to assess facial expression of pain in children
day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2023

Primary Completion (Actual)

March 7, 2023

Study Completion (Actual)

September 12, 2023

Study Registration Dates

First Submitted

August 30, 2022

First Submitted That Met QC Criteria

September 1, 2022

First Posted (Actual)

September 2, 2022

Study Record Updates

Last Update Posted (Actual)

January 12, 2024

Last Update Submitted That Met QC Criteria

January 11, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 21-PP-16
  • 2021-A02726-35 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on intensity of acute pain evaluation

3
Subscribe